Nuclear receptor profiling for subtype classification and as prognostic markers in 33 cancer types
Abstract Nuclear receptors, a group of 48 transcription factors that regulate a multitude of processes within our body, have long been employed as diagnostic markers or therapeutic targets in breast cancer, prostate cancer, and acute promyelocytic leukemia. Unfortunately, no comprehensive investigat...
Saved in:
| Main Authors: | Kazuya Nakamichi, Hironori Suzuki, Yusuke Yamamoto, Kentaro Semba, Jun Nakayama |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-12-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-024-01732-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pan-Cancer Characterization Identifies SLC19A1 as an Unfavorable Prognostic Marker and Associates It with Tumor Infiltration Features
by: Yimin Pan, et al.
Published: (2025-02-01) -
Comprehensive multi-omics analysis showed that CDC6 is a potential prognostic and immunotherapy biomarker for multiple cancer types including HCC
by: Chenxuan Li, et al.
Published: (2025-03-01) -
The role of RETN in stomach adenocarcinoma (STAD): insights from pan-cancer analysis of RNA-seq data based on the TCGA database
by: Yaxing Deng, et al.
Published: (2025-05-01) -
A comprehensive pan-cancer analysis of LRFN4: its potential as a prognostic biomarker and therapeutic target for immunotherapy
by: Yinmei Xu, et al.
Published: (2025-05-01) -
Identification of ferroptosis related genes and subtypes in colorectal cancer
by: Jun Hu, et al.
Published: (2025-07-01)